The present invention relates to compounds of formula (I) useful as inhibitors, in particular as reversible non-covalent inhibitors, of the enzyme monoacylglycerol lipase (MAGL). The present invention also relates to the therapeutic use of such compounds, pharmaceutical compositions that include them and processes for obtaining them.
Monoacylglycerol lipase (MAGL) Inhibitors
Granchi C;Bononi G;Macchia M;Minutolo F;Poli G;Tuccinardi T;
2021-01-01
Abstract
The present invention relates to compounds of formula (I) useful as inhibitors, in particular as reversible non-covalent inhibitors, of the enzyme monoacylglycerol lipase (MAGL). The present invention also relates to the therapeutic use of such compounds, pharmaceutical compositions that include them and processes for obtaining them.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
